Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy.

Conclusions: Fulvestrant showed encouraging clinical activity and favorable feasibility in postmenopausal women with MBC who had been treated with multiple endocrine therapies and/or cytotoxic chemotherapies.
PMID: 29540055 [PubMed - as supplied by publisher]

Source: The Korean Journal of Internal Medicine - March 16, 2018 Category: Internal Medicine Authors: Heo MH, Kim HK, Lee H, Kim JY, Ahn JS, Im YH, Park YH Tags: Korean J Intern Med Source Type: research